Dana-Farber Cancer Institute VP Caltrider Testifies Before Senate Judiciary Subcommittee
October 14, 2025
October 14, 2025
WASHINGTON, Oct. 14 -- The Senate Judiciary Subcommittee on Intellectual Property released the following testimony by Steven P. Caltrider, vice president and chief intellectual property counsel at the Dana-Farber Cancer Institute, from an Oct. 7, 2025, hearing entitled "The Patent Eligibility Restoration Act - Restoring Clarity, Certainty, and Predictability to the U.S. Patent System":
* * *
Thank you, Chairman Tillis, Ranking Member Schiff, and Members of the . . .
* * *
Thank you, Chairman Tillis, Ranking Member Schiff, and Members of the . . .